Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

著者： Annenberg Center for Health Sciences
無料で聴く

  • サマリー

  • Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
    Annenberg Center for Health Sciences
    続きを読む 一部表示

あらすじ・解説

Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
Annenberg Center for Health Sciences
続きを読む 一部表示
エピソード
  • Introduction and Key Takeaways

    Introduction and Key Takeaways
    2024/10/07

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
    続きを読む 一部表示
    15 分

Optimizing Treatment in Patients with ROS1 Rearranged NSCLCに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。